GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (TSXV:MRVL) » Definitions » FCF Yield %

Marvel Biosciences (TSXV:MRVL) FCF Yield % : -23.91 (As of Sep. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Marvel Biosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Marvel Biosciences's Trailing 12-Month Free Cash Flow is C$-1.29 Mil, and Market Cap is C$5.37 Mil. Therefore, Marvel Biosciences's FCF Yield % for today is -23.91%.

The historical rank and industry rank for Marvel Biosciences's FCF Yield % or its related term are showing as below:

TSXV:MRVL' s FCF Yield % Range Over the Past 10 Years
Min: -55.76   Med: 0   Max: 0
Current: -23.91


TSXV:MRVL's FCF Yield % is ranked worse than
62.85% of 1537 companies
in the Biotechnology industry
Industry Median: -13.28 vs TSXV:MRVL: -23.91

Marvel Biosciences's FCF Margin % for the quarter that ended in Apr. 2024 was 0.00%.


Marvel Biosciences FCF Yield % Historical Data

The historical data trend for Marvel Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences FCF Yield % Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23
FCF Yield %
- -17.53 -69.60 -41.85

Marvel Biosciences Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.07 -56.05 -34.47 -22.88 -23.35

Competitive Comparison of Marvel Biosciences's FCF Yield %

For the Biotechnology subindustry, Marvel Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marvel Biosciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's FCF Yield % falls into.



Marvel Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Marvel Biosciences's FCF Yield % for the fiscal year that ended in Jul. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.332 / 3.182896
=-41.85%

Marvel Biosciences's annualized FCF Yield % for the quarter that ended in Apr. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.36 * 4 / 6.166861
=-23.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marvel Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Marvel Biosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Marvel Biosciences Business Description

Traded in Other Exchanges
Address
505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.
Executives
Joseph Roderick Matheson Director, Senior Officer